Compare · EW vs VIRC
EW vs VIRC
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Virco Manufacturing Corporation (VIRC): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while VIRC operates in Consumer Discretionary - the two are in different parts of the market.
- EW is the larger of the two at $49.83B, about 491.6x VIRC ($101.4M).
- EW has hit the wire 5 times in the past 4 weeks while VIRC has been quiet.
- EW has more recent analyst coverage (25 ratings vs 0 for VIRC).
- Company
- Edwards Lifesciences Corporation
- Virco Manufacturing Corporation
- Price
- -
- -
- Market cap
- $49.83B
- $101.4M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 5
- 0
- Recent ratings
- 25
- 0
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Virco Manufacturing Corporation
Virco Mfg. Corporation engages in the design, production, and distribution of furniture for the commercial and education markets in the United States. It offers seating products, including 4-leg chairs, cantilever chairs, tablet arm chairs with work surfaces and compact footprints, steel-frame rockers, stools, series chairs, stack and folding chairs, hard plastic seating, upholstered stack and ergonomic chairs, and plastic stack chairs. The company also provides folding, activity, office, computer, and mobile tables; and computer furniture, such as keyboard mouse trays, CPU holders, support columns, desks and workstations, specialty tables, instructor media stations and towers, and other products. In addition, it offers chair desks, combo units, and tablet arm and caster units, as well as a returns and credenzas. Additionally, the company provides administrative office furniture, including desks, returns, bookcases, storage cabinets, and other items, as well as wardrobe tower cabinets, file credenzas, and mobile pedestals; laboratory furniture comprising steel-based science tables, table bases, lab stools, and wood-frame science tables; mobile furniture, including mobile tables for cafeterias, mobile cabinets, and mobile chairs for school settings and offices; and handling and storage equipment, as well as manufactures stackable storage trucks. It serves educational institutions, convention centers and arenas, hospitality providers, government facilities, and places of worship through its sales and support teams, and dealer network. Virco Mfg. Corporation was founded in 1950 and is headquartered in Torrance, California.
Latest EW
- SEC Form 4 filed by Edwards Lifesciences Corporation
- Barclays initiated coverage on Edwards Lifesciences with a new price target
- Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
- Edwards Lifesciences to Host Investor Event in Conjunction With TCT
- Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
- SVP, Corporate Controller Dahl Andrew M. covered exercise/tax liability with 253 shares, decreasing direct ownership by 2% to 14,615 units (SEC Form 4) to satisfy withholding tax
- CVP, JAPAC Markowitz Wayne covered exercise/tax liability with 923 shares, decreasing direct ownership by 5% to 19,371 units (SEC Form 4) to satisfy tax liability
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $54,169 worth of shares (619 units at $87.51) as part of a pre-agreed trading plan (SEC Form 4)
- CVP, TMTT, Surgical & IHFM Chopra Daveen covered exercise/tax liability with 398 shares, decreasing direct ownership by 0.90% to 43,926 units (SEC Form 4) to satisfy tax liability
- Edwards Lifesciences Comments on TAVR National Coverage Decision
Latest VIRC
- Executive Vice President Virtue Douglas A bought $18,300 worth of Common Stock $.01 par value (3,000 units at $6.10), increasing direct ownership by 0.34% to 897,408 units (SEC Form 4)
- Virco Manufacturing Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 10-Q filed by Virco Manufacturing Corporation
- Virco Reports Revenue through Six Months Declined 6.1% to $118.2 Million from $125.8 Million, as Rebalancing of School Furniture Market Continues
- New insider Massad Wade claimed ownership of 1,590,712 shares (SEC Form 3)
- Executive Vice President Virtue Douglas A bought $34,438 worth of Common Stock $.01 par value (5,740 units at $6.00), increasing direct ownership by 0.65% to 894,408 units (SEC Form 4)
- Executive Vice President Virtue Douglas A bought $48,504 worth of Common Stock $.01 par value (8,088 units at $6.00), increasing direct ownership by 0.92% to 888,668 units (SEC Form 4)
- Executive Vice President Virtue Douglas A bought $8,400 worth of Common Stock $.01 par value (1,400 units at $6.00), increasing direct ownership by 0.16% to 880,580 units (SEC Form 4)
- SEC Form 11-K filed by Virco Manufacturing Corporation
- New insider Wilson Eric Thomas claimed ownership of 1,001 units of Common Stock $.01 par value (SEC Form 3)